Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Murray Huff
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
24
Hegele, Robert
20
Telford, Dawn
18
Wolfe, Bernard
18
Barrett, Hugh
17
Sawyez, Cynthia
13
Edwards, Jane
10
Burnett, John
9
Wilcox, Lisa
8
Clark, William
8
Holub, Bruce
7
Miller, DB
6
Borradaile, Nica
6
Argmann, Carmen
6
Ban, Matthew
6
Pollex, Rebecca
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Murray Huff (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Johnson Charis L; Weston Jacqueline Y; Chadi Sami A; Fazio Elena N; Huff Murray W; Kharitonenkov Alexei; Köester Anja; Pin Christopher L
Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice.
Gastroenterology 2009;137(5):1795-804.
-
2009: Hegele Robert A; Ban Matthew R; Hsueh Neil; Kennedy Brooke A; Cao Henian; Zou Guang Yong; Anand Sonia; Yusuf Salim; Huff Murray W; Wang Jian
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.
Human molecular genetics 2009;18(21):4189-94.
-
2009: Mulvihill Erin E; Allister Emma M; Sutherland Brian G; Telford Dawn E; Sawyez Cynthia G; Edwards Jane Y; Markle Janet M; Hegele Robert A; Huff Murray W
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
Diabetes 2009;58(10):2198-210.
-
2009: Frontini Matthew J; O'Neil Caroline; Sawyez Cynthia; Chan Bosco M C; Huff Murray W; Pickering J Geoffrey
Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells.
Circulation research 2009;104(7):832-41.
-
2008: Wang Jian; Ban Matthew R; Kennedy Brooke A; Anand Sonia; Yusuf Salim; Huff Murray W; Pollex Rebecca L; Hegele Robert A
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Nature clinical practice. Cardiovascular medicine 2008;5(11):730-7.
-
2008: Allister Emma M; Mulvihill Erin E; Barrett P Hugh R; Edwards Jane Y; Carter Lindsey P; Huff Murray W
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
Journal of lipid research 2008;49(10):2218-29.
-
2008: Wang Jian; Ban Matthew R; Zou Guang Yong; Cao Henian; Lin Tim; Kennedy Brooke A; Anand Sonia; Yusuf Salim; Huff Murray W; Pollex Rebecca L; Hegele Robert A
Polygenic determinants of severe hypertriglyceridemia.
Human molecular genetics 2008;17(18):2894-9.
-
2008: Al-Attar Salam A; Pollex Rebecca L; Ban Matthew R; Young T Kue; Bjerregaard Peter; Anand Sonia S; Yusuf Salim; Zinman Bernard; Harris Stewart B; Hanley Anthony Jg; Connelly Philip W; Huff Murray W; Hegele Robert A
Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.
Cardiovascular diabetology 2008;7():5.
-
2007: Lahiry Piya; Ban Matthew R; Pollex Rebecca L; Feldman Ross D; Sawyez Cynthia G; Huff Murray W; Young T Kue; Bjerregaard Peter; Hegele Robert A
Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.
International journal of circumpolar health 2007;66(5):390-400.
-
2007: Telford Dawn E; Sutherland Brian G; Edwards Jane Y; Andrews Joseph D; Barrett P Hugh R; Huff Murray W
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.
Journal of lipid research 2007;48(3):699-708.
-
2007: Beyea Michael M; Heslop Claire L; Sawyez Cynthia G; Edwards Jane Y; Markle Janet G; Hegele Robert A; Huff Murray W
Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol.
The Journal of biological chemistry 2007;282(8):5207-16.
-
2007: Pollex Rebecca L; Ban Matthew R; Young T Kue; Bjerregaard Peter; Anand Sonia S; Yusuf Salim; Zinman Bernard; Harris Stewart B; Hanley Anthony J G; Connelly Philip W; Huff Murray W; Hegele Robert A
Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
BMC medical genetics 2007;8():80.
-
2006: Huff Murray W; Pollex Rebecca L; Hegele Robert A
NPC1L1: evolution from pharmacological target to physiological sterol transporter.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(11):2433-8.
-
2006: Wang Jian; Robinson John F; O'Neil Caroline H; Edwards Jane Y; Williams Christina M; Huff Murray W; Pickering J Geoffrey; Hegele Robert A
Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles.
Journal of human genetics 2006;51(11):934-42.
-
2005: Burnett John R; Telford Dawn E; Barrett P Hugh R; Huff Murray W
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Biochimica et biophysica acta 2005;1738(1-3):10-8.
-
2005: Telford Dawn E; Lipson Sara M; Barrett P Hugh R; Sutherland Brian G; Edwards Jane Y; Aebi Johannes D; Dehmlow Henrietta; Morand Olivier H; Huff Murray W
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2608-14.
-
2005: Huff Murray W; Telford Dawn E
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.
Trends in pharmacological sciences 2005;26(7):335-40.
-
2005: Carter David E; Robinson John F; Allister Emma M; Huff Murray W; Hegele Robert A
Quality assessment of microarray experiments.
Clinical biochemistry 2005;38(7):639-42.
-
2005: Allister Emma M; Borradaile Nica M; Edwards Jane Y; Huff Murray W
Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes.
Diabetes 2005;54(6):1676-83.
-
2005: Argmann Carmen A; Edwards Jane Y; Sawyez Cynthia G; O'Neil Caroline H; Hegele Robert A; Pickering J Geoffrey; Huff Murray W
Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
The Journal of biological chemistry 2005;280(23):22212-21.
-
2004: Argmann Carmen A; Sawyez Cynthia G; Li Shaohua; Nong Zengxuan; Hegele Robert A; Pickering J Geoffrey; Huff Murray W
Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(7):1290-6.
-
2003: Borradaile Nica M; de Dreu Linda E; Huff Murray W
Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation.
Diabetes 2003;52(10):2554-61.
-
2003: Rowe Andrea H; Argmann Carmen A; Edwards Jane Y; Sawyez Cynthia G; Morand Olivier H; Hegele Robert A; Huff Murray W
Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
Circulation research 2003;93(8):717-25.
-
2003: Telford Dawn E; Edwards Jane Y; Lipson Sara M; Sutherland Brian; Barrett P Hugh R; Burnett John R; Krul Elaine S; Keller Bradley T; Huff Murray W
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
Journal of lipid research 2003;44(5):943-52.
-
2003: Argmann C A; Sawyez C G; McNeil C J; Hegele R A; Huff M W
Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(3):475-82.
-
2003: Borradaile Nica M; de Dreu Linda E; Barrett P Hugh R; Behrsin Colleen D; Huff Murray W
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
Biochemistry 2003;42(5):1283-91.
-
2003: Huff Murray W
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2003;10 Suppl A():26A-32A.
-
2002: Huff Murray W; Telford Dawn E; Edwards Jane Y; Burnett John R; Barrett P Hugh R; Rapp Stephen R; Napawan Nida; Keller Bradley T
Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1884-91.
-
2002: Borradaile Nica M; de Dreu Linda E; Barrett P Hugh R; Huff Murray W
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Journal of lipid research 2002;43(9):1544-54.
-
2002: Borradaile Nica M; de Dreu Linda E; Wilcox Lisa J; Edwards Jane Y; Huff Murray W
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.
The Biochemical journal 2002;366(Pt 2):531-9.
-
2002: Al-Shali Khalid; Wang Jian; Fellows Fraser; Huff Murray W; Wolfe Bernard M; Hegele Robert A
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
Clinical biochemistry 2002;35(2):125-30.
-
2001: Argmann C A; Van Den Diepstraten C H; Sawyez C G; Edwards J Y; Hegele R A; Wolfe B M; Huff M W
Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(12):2011-8.
-
2001: Wilcox L J; Borradaile N M; de Dreu L E; Huff M W
Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
Journal of lipid research 2001;42(5):725-34.
-
2000: Wolfe B M; Barrett P H; Laurier L; Huff M W
Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women.
Journal of lipid research 2000;41(3):368-75.
-
1999: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Endocrinology 1999;140(11):5293-302.
-
1999: Burnett J R; Wilcox L J; Huff M W
Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
Clinica chimica acta; international journal of clinical chemistry 1999;286(1-2):231-42.
-
1999: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Journal of lipid research 1999;40(7):1317-27.
-
1999: Wilcox L J; Barrett P H; Huff M W
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Journal of lipid research 1999;40(6):1078-89.
-
1999: Whitman S C; Argmann C A; Sawyez C G; Miller D B; Hegele R A; Huff M W
Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.
Journal of lipid research 1999;40(6):1017-28.
-
1999: Whitman S C; Hazen S L; Miller D B; Hegele R A; Heinecke J W; Huff M W
Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1238-49.
-
1999: Wilcox L J; Barrett P H; Newton R S; Huff M W
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):939-49.
-
1998: Burnett J R; Barrett P H; Vicini P; Miller D B; Telford D E; Kleinstiver S J; Huff M W
The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(12):1906-14.
-
1998: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Huff M W
Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Biochimica et biophysica acta 1998;1393(1):63-79.
-
1998: Whitman S C; Sawyez C G; Miller D B; Wolfe B M; Huff M W
Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL.
Journal of lipid research 1998;39(5):1008-20.
-
1997: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2589-600.
-
1997: Whitman S C; Miller D B; Wolfe B M; Hegele R A; Huff M W
Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1707-15.
-
1997: Huff M W; Miller D B; Wolfe B M; Connelly P W; Sawyez C G
Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
Journal of lipid research 1997;38(7):1318-33.
-
1997: Huff M W; Burnett J R
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.
Current opinion in lipidology 1997;8(3):138-45.
-
1996: Ingram A J; Parbtani A; Clark W F; Spanner E; Huff M W; Philbrick D J; Holub B J; Scholey J W
Dietary alteration of dihomogamma-linolenic acid/arachidonic acid ratio in a rat 5/6-renal-ablation model. The Nutrition & Kidney Disease Research Group.
Journal of the American Society of Nephrology : JASN 1996;7(7):1024-31.
-
1996: Cianflone K; Avramoglu R K; Sawyez C; Huff M W
Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Atherosclerosis 1996;120(1-2):101-14.
-
1995: Clark W F; Parbtani A; Huff M W; Spanner E; de Salis H; Chin-Yee I; Philbrick D J; Holub B J
Flaxseed: a potential treatment for lupus nephritis.
Kidney international 1995;48(2):475-80.
-
1995: Pflugfelder P W; Huff M; Oskalns R; Rudas L; Kostuk W J
Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1995;14(4):613-22.
-
1995: Wolfe B M; Huff M W
Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women.
Metabolism: clinical and experimental 1995;44(3):410-7.
-
1995: Miller D B; Hegele R A; Wolfe B M; Huff M W
Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
The Journal of clinical endocrinology and metabolism 1995;80(3):807-13.
-
1995: Ingram A J; Parbtani A; Clark W F; Spanner E; Huff M W; Philbrick D J; Holub B J
Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(2):320-9.
-
1994: Huff M W; Telford D E; Barrett P H; Billheimer J T; Gillies P J
Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1498-508.
-
1994: Walden C C; Huff M W; Leiter L A; Connelly P W; Hegele R A
Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
The Journal of clinical endocrinology and metabolism 1994;78(3):699-704.
-
1993: Huff M W; Telford D E; Edmonds B W; McDonald C G; Evans A J
Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil.
Biochimica et biophysica acta 1993;1210(1):113-22.
-
1993: Huff M W; Sawyez C G; Connelly P W; Maguire G F; Little J A; Hegele R A
Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(9):1282-90.
-
1993: Clark W F; Parbtani A; Naylor C D; Levinton C M; Muirhead N; Spanner E; Huff M W; Philbrick D J; Holub B J
Fish oil in lupus nephritis: clinical findings and methodological implications.
Kidney international 1993;44(1):75-86.
-
1993: Wolfe B M; Huff M W
Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.
The Journal of clinical investigation 1993;92(1):456-61.
-
1993: Clark W F; Parbtani A; Philbrick D J; Spanner E; Huff M W; Holub B J
Dietary protein restriction versus fish oil supplementation in the chronic remnant nephron model.
Clinical nephrology 1993;39(6):295-304.
-
1993: Evans A J; Sawyez C G; Wolfe B M; Connelly P W; Maguire G F; Huff M W
Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
Journal of lipid research 1993;34(5):703-17.
-
1993: Evans A J; Wolfe B M; Strong W L; Huff M W
Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Metabolism: clinical and experimental 1993;42(1):105-15.
-
1992: Hall A V; Parbtani A; Clark W F; Spanner E; Huff M W; Philbrick D J; Holub B J
Omega-3 fatty acid supplementation in primary nephrotic syndrome: effects on plasma lipids and coagulopathy.
Journal of the American Society of Nephrology : JASN 1992;3(6):1321-9.
-
1992: Huff M W; Telford D E; Barrett P H
Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):902-10.
-
1992: Evans A J; Sawyez C G; Wolfe B M; Huff M W
Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
The Journal of biological chemistry 1992;267(15):10743-51.
-
1991: Huff M W
Fibrates and HMG-CoA reductase inhibitors.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1991;145(8):977.
-
1991: Clark W F; Parbtani A; Philbrick D J; Holub B J; Huff M W
Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model.
Journal of the American Society of Nephrology : JASN 1991;1(12):1343-53.
-
1991: Huff M W; Evans A J; Sawyez C G; Wolfe B M; Nestel P J
Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(2):221-33.
-
1991: Hegele R A; Connelly P W; Maguire G F; Huff M W; Leiter L; Wolfe B M; Evans A J; Little J A
An apolipoprotein CII mutation, CIILys19----Thr' identified in patients with hyperlipidemia.
Disease markers 1991;9(2):73-80.
-
1990: Huff M W; Evans A J; Wolfe B M; Connelly P W; Maguire G F; Strong W L
Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
Journal of lipid research 1990;31(3):385-96.
-
1989: Evans A J; Huff M W; Wolfe B M
Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
Journal of lipid research 1989;30(11):1691-701.
-
1989: Huff M W
Research horizons in hyperlipidemia and atherosclerosis.
The Canadian journal of cardiology 1989;5(7):VIII.
-
1989: Clark W F; Parbtani A; Huff M W; Reid B; Holub B J; Falardeau P
Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.
Kidney international 1989;36(4):653-60.
-
1989: Khosla P; Samman S; Carroll K K; Huff M W
Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein.
Biochimica et biophysica acta 1989;1002(2):157-63.
-
1989: Huff M W; Telford D E
Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
Metabolism: clinical and experimental 1989;38(3):256-64.
-
1989: Huff M W; Telford D E
Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
Arteriosclerosis (Dallas, Tex.) 1989;9(1):58-66.
-
1989: Wolfe B M; Huff M W
Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women.
The Journal of clinical investigation 1989;83(1):40-5.
-
1988: Huff M W; Breckenridge W C; Strong W L; Wolfe B M
Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
Arteriosclerosis (Dallas, Tex.) 1988;8(5):471-9.
-
1987: Huff M W; Strong W L
Separation and isolation of human apolipoproteins C-II, C-III0, C-III1, and C-III2 by chromatofocusing on the Fast Protein Liquid Chromatography system.
Journal of lipid research 1987;28(9):1118-23.
-
1985: Huff M W; Telford D E; Woodcroft K; Strong W L
Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs.
Journal of lipid research 1985;26(10):1175-86.
-
1985: Huff M W; Telford D E
Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig.
Metabolism: clinical and experimental 1985;34(1):36-42.
-
1984: Huff M W; Telford D E
Characterization and metabolic fate of two very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography.
Biochimica et biophysica acta 1984;796(3):251-61.
Sign-in to see more
